Clinical Trial Update: A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract [Phase 2]

View source ↗

Summary

Phase 2 trial of tadalafil in patients with head and neck squamous cell carcinoma has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-06-11